Literature DB >> 9244352

The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?

O Lustig-Yariv1, E Schulze, D Komitowski, V Erdmann, T Schneider, N de Groot, A Hochberg.   

Abstract

H19 is a paternally imprinted gene with unknown function. It is located in close proximity to the maternally imprinted IGF-2 gene on chromosome 11p15.5. In this study no consistent relationship between the expression of these two genes in clones derived from JEG-3 and JAr cell lines could be detected. Nor could a consistent relationship be detected between the expression levels of these two genes and between certain characteristic tumorigenic properties of these clones. We included in this study clones, expressing low H19 levels, which after transfection with an H19 expression construct highly expressed the H19 gene. In tumors, formed by the injection of cells of JAr or JEG-3 clones into nude mice, the H19 expression was high and irrelevant to the expression level in the cells before the injection. The same phenomenon was found for IGF-2 expression during tumorigenesis caused by cells of different JEG-3 clones and in some but not all JAr derived clones. Both H19 and IGF-2 are biallelicly expressed in all the JAr and JEG-3 clones. In summary, our observations point to the conclusion that H19 is not a tumor suppressor gene. However, its high expression in all the tumors formed after injection of cells of the JAr and JEG-3 clones, leaves its role, if any, in choriocarcinogenesis an open question.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9244352     DOI: 10.1038/sj.onc.1201175

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Hochberg; Smadar Amiur; Jennifer Gallula; Imad Matouk; Tatiana Birman; Tally Levy; Sorin Ladimir; Patricia Ohana
Journal:  Int J Clin Exp Med       Date:  2010-09-21

Review 2.  Genomic imprinting and cancer.

Authors:  J A Joyce; P N Schofield
Journal:  Mol Pathol       Date:  1998-08

3.  H19 expression in hepatic metastases from a range of human carcinomas.

Authors:  Y Fellig; I Ariel; P Ohana; P Schachter; I Sinelnikov; T Birman; S Ayesh; T Schneider; N de Groot; A Czerniak; A Hochberg
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.

Authors:  I Ariel; M Sughayer; Y Fellig; G Pizov; S Ayesh; D Podeh; B A Libdeh; C Levy; T Birman; M L Tykocinski; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  2000-12

5.  Characterization of human and mouse H19 regulatory sequences.

Authors:  G Banet; O Bibi; I Matouk; S Ayesh; M Laster; K M Kimber; M Tykocinski; N de Groot; A Hochberg; P Ohana
Journal:  Mol Biol Rep       Date:  2000-09       Impact factor: 2.316

6.  Modeling familial cancer with induced pluripotent stem cells.

Authors:  Dung-Fang Lee; Jie Su; Huen Suk Kim; Betty Chang; Dmitri Papatsenko; Ruiying Zhao; Ye Yuan; Julian Gingold; Weiya Xia; Henia Darr; Razmik Mirzayans; Mien-Chie Hung; Christoph Schaniel; Ihor R Lemischka
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

7.  The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.

Authors:  Ling Ma; Xiaodong Tian; Feng Wang; Zhengkui Zhang; Chong Du; Xuehai Xie; Marko Kornmann; Yinmo Yang
Journal:  Cancer Biol Ther       Date:  2016-08-29       Impact factor: 4.742

8.  Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer.

Authors:  V Scaiewicz; V Sorin; Y Fellig; T Birman; A Mizrahi; J Galula; R Abu-Lail; T Shneider; P Ohana; L Buscail; A Hochberg; A Czerniak
Journal:  J Oncol       Date:  2010-10-28       Impact factor: 4.375

9.  The H19 locus acts in vivo as a tumor suppressor.

Authors:  Tomomi Yoshimizu; Audrey Miroglio; Marie-Anne Ripoche; Anne Gabory; Maria Vernucci; Andrea Riccio; Sabine Colnot; Cécile Godard; Benoit Terris; Hélène Jammes; Luisa Dandolo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

10.  Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Czerniak; Tally Levy; Smadar Amiur; Jennifer Gallula; Imad Matouk; Rasha Abu-lail; Vladimir Sorin; Tatiana Birman; Nathan de Groot; Abraham Hochberg; Patricia Ohana
Journal:  J Transl Med       Date:  2009-08-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.